Cipla Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For CIPLA, that strike is ₹1,400. Spot at ₹1,385 is 1.1% below max pain — possible upward gravitational pull into expiry.
Max Pain Level
The options market for Cipla Limited (CIPLA) shows a max‑pain strike at ₹1,400. This level represents the price at which option writers would incur the smallest aggregate loss, acting as a magnet as expiry approaches.
Spot vs Max Pain Gap
The current spot price of ₹1,385 sits ₹15 below the max‑pain level, indicating a modest upside pull‑back pressure toward the strike. The 1.07 % gap suggests the market is not far from the point where call writers would prefer the underlying to settle.
Shift Signal
The max‑pain figure has moved ₹10 down from yesterday, reflecting a recent downward bias among option writers. Such a shift hints that short‑call positions are being adjusted to a lower strike, reinforcing the pull‑back dynamic.
Expiry Context
Max‑pain theory posits that, all else equal, the underlying price tends to converge toward the strike where the total open‑interest payout is minimized near expiry. However, this is a statistical tendency and not a deterministic outcome; market news or liquidity shocks can still drive the price away.
Data Note
With 25 days remaining until the September 29 expiry, the spot price remains ₹15 below the max‑pain level.
Data as of 2026-09-04